How FDA’s New Real-World Data Guidance Solves 3 Big Problems
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
The rise of GLP-1 therapies and the evolution of obesity treatment Over 40% of adults in the U.S. have obesity, representing over 100 million patients.1 Not long ago, bariatric surgery was the only option for substantial weight loss among those with ...